Canada markets close in 3 hours 2 minutes

AEON Biopharma, Inc. (AEON)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
1.6500-0.0800 (-4.62%)
As of 12:45PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 67.09M
Enterprise Value 62.21M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)97.16
Price/Book (mrq)N/A
Enterprise Value/Revenue 201.68
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.76
52-Week Change 3-81.20%
S&P500 52-Week Change 326.27%
52 Week High 317.1700
52 Week Low 31.3800
50-Day Moving Average 38.2968
200-Day Moving Average 36.9472

Share Statistics

Avg Vol (3 month) 395.18k
Avg Vol (10 day) 3191.55k
Shares Outstanding 538.78M
Implied Shares Outstanding 638.78M
Float 815.46M
% Held by Insiders 140.50%
% Held by Institutions 123.93%
Shares Short (Apr 30, 2024) 4191.93k
Short Ratio (Apr 30, 2024) 42.86
Short % of Float (Apr 30, 2024) 40.88%
Short % of Shares Outstanding (Apr 30, 2024) 40.49%
Shares Short (prior month Mar 28, 2024) 4359.59k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-374.77%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -52.74M
Net Income Avi to Common (ttm)-36.63M
Diluted EPS (ttm)-0.3600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.16M
Total Cash Per Share (mrq)0.14
Total Debt (mrq)278k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.48
Book Value Per Share (mrq)-4.12

Cash Flow Statement

Operating Cash Flow (ttm)-47.83M
Levered Free Cash Flow (ttm)-25.48M